Sign In

Marcio Scorsin

Consultant Cardiac Surgeon at Jilin Heart Hospital & Inventor and Consultant at Epygon

Marcio Scorsin is a highly accomplished cardiac surgeon and researcher with over 25 years of experience in developing innovative surgical techniques in adult cardiac surgery.

He is the founder of Myosix, a start-up focusing on producing embrionary cells to regenerate the myocardium, which was later acquired by Genzyme.

His inventions include a patented device for mitral valve repair and a new device application for myocardial viability detection.

As the co-founder and Chief Medical Officer of Epygon, he led the development of a transcatheter mitral prosthesis with unique geometry and advanced leaflet structure for optimal fitting and physiological hemodynamic function.

Marcio Scorsin is also involved in other ventures like Toucan Health Innovations, ValSculp, and S-form Pharma, all aimed at advancing heart failure diagnosis and treatment.

His specialties include cellular transplantation, mitral repair, arterial off-pump CABG, aortic aneurysm, and left ventricular remodelling.

Marcio Scorsin's educational background includes a PhD in Surgery and a Master's Degree in Surgical Science from Universite Paris Descartes-Paris V, among other prestigious qualifications from various institutions.

He has held prominent positions as Consultant Cardiac Surgeon at Jilin Heart Hospital, Chief Medical Officer at Epygon, and Cardiac Surgeon at APHP.

Marcio Scorsin's contributions to the field of cardiac surgery have been impactful, with his research and entrepreneurial endeavors demonstrating his commitment to innovation and improving patient outcomes.

Marcio Scorsin
Add to my network

Location

Changchun, Jilin, China